​

Abeona Therapeutics (ABEO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

ABEO Stock Forecast

Abeona Therapeutics (ABEO) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $16.00, with a high of $16.00 and a low of $16.00. This represents a 230.58% increase from the last price of $4.84.

- $4 $8 $12 $16 $20 High: $16 Avg: $16 Low: $16 Last Closed Price: $4.84

ABEO Stock Rating

Abeona Therapeutics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 4 Strong Sell Sell Hold Buy Strong Buy

ABEO Price Target Upside V Benchmarks

TypeNameUpside
StockAbeona Therapeutics230.58%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$16.00$16.00
Last Closing Price$4.84$4.84$4.84
Upside/Downside-230.58%230.58%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2514---5
Mar, 2513---4
Feb, 2513---4
Jan, 2514---5
Dec, 2414---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 05, 2025Oppenheimer$16.00$5.26204.18%230.58%
Nov 14, 2022Leerink Partners$6.00$4.1544.58%23.97%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 05, 2025OppenheimerOutperforminitialise
Jul 03, 2024H.C. WainwrightBuyinitialise
May 16, 2024Cantor FitzgeraldOverweightOverweighthold
Nov 14, 2022SVB LeerinkMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

$-35 $-25 $-15 $-5 $5 $15 Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-23.84$-4.05$-2.53$-0.16----
Avg Forecast$-20.58$-3.92$-2.23$-1.65$-1.19$-0.39$1.50$4.09
High Forecast$-9.48$-2.80$-1.58$-1.57$-0.99$-0.08$12.86$6.31
Low Forecast$-32.90$-6.44$-3.44$-1.72$-1.48$-0.87$-9.86$2.89
Surprise %15.84%3.32%13.45%-90.30%----

Revenue Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.00M$1.41M$3.50M-----
Avg Forecast$12.37M$2.32M$3.63M$125.00K$19.78M$75.92M$217.60M$397.20M
High Forecast$18.06M$3.48M$5.14M$177.22K$26.88M$107.63M$308.50M$563.12M
Low Forecast$7.23M$1.81M$2.81M$96.89K$16.06M$58.85M$168.67M$307.88M
Surprise %-19.14%-39.13%-3.45%-----

Net Income Forecast

$-750M $-540M $-330M $-120M $90M $300M Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-88.35M$-31.81M$-54.19M$-63.73M----
Avg Forecast$-440.08M$-83.70M$-54.19M$-35.13M$-26.38M$-10.18M$8.95M$87.45M
High Forecast$-202.61M$-59.77M$-33.74M$-33.58M$-21.15M$-1.70M$274.89M$134.93M
Low Forecast$-703.51M$-137.68M$-73.57M$-36.69M$-31.62M$-18.66M$-210.75M$61.88M
Surprise %-79.92%-62.00%-81.42%----

ABEO Forecast FAQ

Is Abeona Therapeutics stock a buy?

Abeona Therapeutics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Abeona Therapeutics is a favorable investment for most analysts.

What is Abeona Therapeutics's price target?

Abeona Therapeutics's price target, set by 7 Wall Street analysts, averages $16 over the next 12 months. The price target range spans from $16 at the low end to $16 at the high end, suggesting a potential 230.58% change from the previous closing price of $4.84.

How does Abeona Therapeutics stock forecast compare to its benchmarks?

Abeona Therapeutics's stock forecast shows a 230.58% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Abeona Therapeutics over the past three months?

  • April 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Abeona Therapeutics’s EPS forecast?

Abeona Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.19, marking a 643.75% increase from the reported $-0.16 in 2024. Estimates for the following years are $-0.39 in 2026, $1.5 in 2027, and $4.09 in 2028.

What is Abeona Therapeutics’s revenue forecast?

Abeona Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $19.78M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $75.92M, followed by $217.6M for 2027, and $397.2M for 2028.

What is Abeona Therapeutics’s net income forecast?

Abeona Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-26.383M, representing a -58.60% decrease from the reported $-63.734M in 2024. Projections indicate $-10.176M in 2026, $8.95M in 2027, and $87.45M in 2028.